RxDoctor Payments Data

Amy Yeatman, DO

Interventional Pain Medicine · Green Bay, WINPI 1700869468

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,606 of the $4,563 with a category attached, or 79.0%. Surgentec accounts for 73.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $2,783 and has fallen 95.8% since, to $117 in 2025.

$4,563in general payments, 2019–2025

Across 21 payments — averaging $217.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgentec$3K
  • Boston Scientific$611
  • Medtronic$373
  • Biogen$108
  • Abbott$58
  • Si-bone, Inc.$55
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$3,60679%
  • Food & beverage$95721%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Surgentec2$3,342
Boston Scientific5$611
Medtronic(2 entities)9$373
Biogen1$108
Abbott1$58
Si-bone, Inc.2$55
Vertex1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,563 in reported general payments places this provider in the 55th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$70,585
Medicare patients
324
Services billed
726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LyricaPregabalin13$13,452
Gabapentin41$778
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$583
Pregabalin33$286
Tramadol Hcl21$52

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Green Bay

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →